Setbone Medical

Setbone Medical Overview

SetBone Medical is developing a novel bone cement for the treatment of vertebral compression fractures (VCF) primarily caused by osteoporosis. The company’s proprietary acrylic bone cement seeks to overcome the limitations of current cements and provide physicians with a safer and more efficient work environment. SetBone’s cement does not contain any toxic monomers. It comes in a ready-to-use, prefilled cartridge and can be used right out of the box with no preparation required. The dual-paste, mix-on injection allows extended working time, and its low exothermic reaction keeps the cement curing temperature low and prevents damage to surrounding tissue.

Cumulative Funding Raised Over Time ($)

Latest News

Jan 16, 2022 · www.prnewswire.com

growth-positive

SetBone Medical Announces $1.6 Million Financing

SetBone Medical Ltd. has closed an oversubscribed investment round of $1.6 million. The funds raised will support the next stage of development and initiation of a First in Human pilot study. SetBone Medical has developed a patent-pending bone cement for use in orthopedic and spine procedures, with the first product indication being the treatment of Vertebral Compression Fractures (VCF). The companys bone cement is ready-to-use and does not contain toxic monomers, providing a safer and more efficient treatment option. The global bone cement market is projected to reach $1.4 billion by 2028. SetBone Medical is a portfolio company of the Trendlines Group.

Investment

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Pinhas Sapir St 7, Ness Ziona, Israel

Photos & Videos

1 item(s)

Setbone Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info